Related Experiment Videos
Comparative evaluation of two membrane-based liposomal MRI contrast agents
S Karlik1, E Florio, C W Grant
1Department of Diagnostic Radiology, University Hospital, London, Canada.
Magnetic Resonance in Medicine
|May 1, 1991
Summary
Liposomal gadolinium contrast agents offer superior MRI enhancement compared to spin-label agents. These gadolinium-based liposomes provide prolonged imaging contrast, especially in intramuscular injections.
Area of Science:
- Biomedical Imaging
- Materials Science
- Pharmacology
Background:
- Liposomes are utilized as drug delivery vehicles and contrast agents.
- Developing effective liposomal contrast agents for Magnetic Resonance Imaging (MRI) is crucial for diagnostic imaging.
- Gadolinium and spin-label agents are explored for their potential in liposomal formulations.
Purpose of the Study:
- To compare the in vivo efficacy of two novel liposomal contrast agents for MRI.
- To evaluate the biodistribution and contrast enhancement properties of spin-label and gadolinium-bound phospholipids.
- To assess the duration of contrast enhancement following different administration routes.
Main Methods:
- Two types of phospholipids were synthesized: one with a nitroxide free radical and another with a gadolinium-chelating agent.
- These phospholipids were incorporated into sonicated unilamellar vesicles to form liposomal contrast agents.
- In vivo studies were conducted in rats, involving intramuscular and intravenous injections.
- MRI was performed to assess contrast enhancement and biodistribution.
- Fat suppression techniques were employed as an adjunct imaging method.
Main Results:
- Liposomal gadolinium demonstrated significantly higher potency in highlighting liposome biodistribution compared to the spin-label analogue.
- Intramuscular injection of liposomal gadolinium resulted in contrast lasting over 24 hours, whereas spin-label liposomes provided contrast for only 1 hour.
- Water-soluble DTPA-Gd3+ showed rapid clearance from intramuscular sites within 15 minutes.
- Intravenous administration of both liposomal agents led to maximum effect in the liver and spleen within 1-2 hours, with spin-label agents yielding marginal contrast.
- Fat suppression improved imaging of reticuloendothelial system organs.
Conclusions:
- Liposomal contrast agents containing gadolinium are more effective and provide longer-lasting contrast than spin-label analogues for MRI.
- The biodistribution and clearance profiles differ significantly between liposomal and non-liposomal agents, as well as between gadolinium and spin-label liposomes.
- Liposomal gadolinium represents a promising contrast agent for enhanced diagnostic imaging, particularly for tracking liposome distribution over extended periods.